Skip to main content
Premium Trial:

Request an Annual Quote

MicroGenDx Acquires Sequencing Lab RTL Genomics

NEW YORK — MicroGenDx said on Wednesday that it has acquired next-generation sequencing laboratory RTL Genomics.

Financial terms of the transaction were not disclosed.

MicroGenDx, which provides sequencing- and PCR-based microbial testing for clinical diagnostic applications, said the deal would help expand its capabilities in nonclinical primary research.

MicroGenDx said it has built a reference database of over 50,000 microbial species based on ITS and 16S sequencing and that the addition of RTL will help it create a similar database with whole-genome sequencing.

"Developing a comprehensive reference database for shotgun sequencing is our long-term goal," Eric Rees, MicroGenDx's chief technology officer, said in a statement. "By evaluating and comparing the bioinformatic performance of our clinical and research workflows, we can now expand datasets and refine our software for both much more rapidly."

MicroGenDx and RTL, both based in Lubbock, Texas, were originally divisions of Southwest Regional PCR. They were spun off into separate businesses in 2017.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.